|
ZFP14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.8516000000044E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.438560E-04 |
| Normal-vs-Stage2 |
1.202260E-02 |
| Normal-vs-Stage3 |
1.94730000002696E-06 |
| Normal-vs-Stage4 |
6.46479999977245E-07 |
| Stage1-vs-Stage2 |
4.876600E-01 |
| Stage1-vs-Stage3 |
1.653400E-01 |
| Stage1-vs-Stage4 |
1.309600E-02 |
| Stage2-vs-Stage3 |
1.392810E-01 |
| Stage2-vs-Stage4 |
3.209700E-02 |
| Stage3-vs-Stage4 |
2.907600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.4980999999924E-05 |
| Normal-vs-AfricanAmerican |
2.044000E-02 |
| Normal-vs-Asian |
8.598200E-04 |
| Caucasian-vs-AfricanAmerican |
5.882600E-01 |
| Caucasian-vs-Asian |
4.227600E-01 |
| AfricanAmerican-vs-Asian |
9.525600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.039480E-04 |
| Normal-vs-Female |
2.35539999999812E-05 |
| Male-vs-Female |
4.371200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.210840E-04 |
| Normal-vs-Age(41-60Yrs) |
1.55344999999141E-05 |
| Normal-vs-Age(61-80Yrs) |
4.4601000000033E-05 |
| Normal-vs-Age(81-100Yrs) |
4.673600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.200800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.029400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.377800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.662600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.520800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.519800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.248700E-04 |
| Classical-VS-Follicular |
3.704400E-01 |
| Classical-VS-Other |
6.493800E-01 |
| Classical-VS-Normal |
4.588200E-04 |
| Tall-VS-Follicular |
1.340210E-02 |
| Tall-VS-Other |
2.353400E-01 |
| Tall-VS-Normal |
8.50610000213692E-08 |
| Follicular-VS-Other |
8.893400E-01 |
| Follicular-VS-Normal |
1.215560E-04 |
| Other-VS-Normal |
7.863600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.70920000000163E-05 |
| Normal-vs-N1 |
1.52605999999E-05 |
| N0-vs-N1 |
1.573220E-01 |
|
|
